Bausch Health Companies Inc.
6.16USD
-0.2700 (-4.20%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,852 | 2,524 | 2,796 | 2,681 | 2,530 | 2,259 | 2,559 | 2,510 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Operating Income | 740 | -950 | 474 | 619 | 444 | 276 | 558 | 318 |
| Net Income | 258 | -1,423 | -112 | 179 | 148 | -58 | 93 | -85 |
| EPS (Diluted) | $0.68 | $-3.82 | $-0.30 | $0.48 | $0.40 | $-0.16 | $0.25 | $-0.23 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)